Human Mesenchymal Stem Cells Persist, Demonstrate Site-Specific Multipotential Differentiation, and Are Present in Sites of Wound Healing and Tissue Regeneration after Transplantation into Fetal Sheep-Reference-Cited by-同舟云学术

Human Mesenchymal Stem Cells Persist, Demonstrate Site-Specific Multipotential Differentiation, and Are Present in Sites of Wound Healing and Tissue Regeneration after Transplantation into Fetal Sheep

Published:2001-05 Issue:3 Volume:27 Page:601-604
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Mackenzie Tippi C.,Flake Alan W.

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference21 articles.

1. Marrow stromal cells as stem cells for nonhematopoietic tissues;Prockop;Science,1997

2. Multilineage potential of adult human mesenchymal stem cells;Pittenger;Science,1999

3. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine;Wakitani;Muscle Nerve,1995

4. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases;Koc;Exp. Hematol.,1999

5. “Actively acquired tolerance” of foreign cells;Billingham;Nature,1953

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of Artificial Nerve Conduits Used in a Long Nerve Gap: Current Reviews and Future Studies;Bioengineering;2024-04-22

2. Global signatures of the human mesenchymal stromal cell secretome: A comparative proteomic analysis of iPSC and tissue-derived MSC secretomes before and after inflammatory licensing;2024-04-05

3. Epigallocatechin-3-gallate maintains Th1/Th2 response balance and mitigates type-1 autoimmune diabetes induced by streptozotocin through promoting the effect of bone-marrow-derived mesenchymal stem cells;Gene;2024-02

4. Organogenesis and related approaches for organ replacement;Living Donor Organ Transplantation;2024

5. Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain: an update;Expert Opinion on Therapeutic Targets;2023-08-03